Japan's Sawai gets U.S. production with $1B deal for Upsher-Smith generics

5th June 2017 Uncategorised 0

Japan’s Sawai is following the path tread by other drugmakers with big plans for the U.S., establishing a U.S. manufacturing beachhead by acquiring a U.S. generics operation.

More: Japan's Sawai gets U.S. production with B deal for Upsher-Smith generics
Source: fierce